Institut für Rekonstruktive Neurobiologie

Prof. Dr. Oliver Brüstle

Institut für Rekonstruktive Neurobiologie

Universitätsklinikum Bonn

Website Publikationen

Our working group is employing embryonic stem cells, induced pluripotent stem (iPS) cells and direct cell conversion technologies for studying the earliest steps in the molecular pathogenesis of neurodegenerative and neuropsychiatric diseases and for devising novel cell therapies. Today, cell reprogramming and direct cell fate conversion enable standardized derivation of patient-specific brain and spinal cord cells from a few milliliters of blood or a small skin sample. The Brüstle team uses this unique patient-specific resource for in vitro disease modeling, drug development and personalized medicine including neural transplantation and autologous cell therapy. IRN researchers have been pioneering the differentiation of pluripotent stem cells into various neural stem and progenitor cell types, which provide an important basis for standardization of our disease modeling and drug testing applications.

Tags:  Neurale Stammzellen  Induzierte pluripotente Stammzellen  Embryonale Stammzellen  Nervensystem  Reprogrammierung  Entwicklungsbiologie  Organoide  Krankheitsmodellierung  Präklinische Studien  Altern  Drug Screening/Discovery  Genome Editing  Transplantation  Translation